Antibodies designed from scratch with RFdiffusion
Baker’s group showed RFdiffusion can be adapted to generate antibodies: in laboratory tests, designs bound influenza virus and other targets as intended. Proof-of-concept study, first circulated as a preprint in March 2024; experts quoted by Nature call it promising but an early step; no affinity values reported.
Technology: RFdiffusion
Family RFdiffusion: profile · models page
Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Preprint
- Test type: direct test
- Tested: Laboratory tests confirmed that the designed antibodies bind influenza virus and other targets as intended; no affinity values are reported.
- Still unknown: The work is described as a proof-of-concept study, and no specific limitations are listed.
- AI role: RFdiffusion was tuned to generate antibodies from scratch.
Evidence sources: https://www.ipd.uw.edu/2024/04/nature-a-landmark-moment-scientists-use-ai-to-design-antibodies-from-scratch/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: press release. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.